S&P 500   3,324.26 (-0.16%)
DOW   29,223.57 (-0.42%)
QQQ   223.47 (+0.04%)
AAPL   316.91 (-0.57%)
FB   221.13 (-0.45%)
MSFT   166.98 (-0.07%)
GOOGL   1,483.87 (+0.29%)
AMZN   1,882.57 (+0.96%)
CGC   24.10 (-3.17%)
NVDA   248.28 (-0.40%)
BABA   222.18 (-2.31%)
MU   58.91 (+2.17%)
GE   11.68 (-1.10%)
TSLA   543.81 (+6.52%)
AMD   51.15 (+0.43%)
T   38.63 (+0.63%)
ACB   2.00 (-6.12%)
F   9.19 (+0.33%)
NFLX   337.57 (-0.62%)
PRI   127.04 (-1.08%)
BAC   34.38 (-0.95%)
GILD   62.67 (-0.49%)
S&P 500   3,324.26 (-0.16%)
DOW   29,223.57 (-0.42%)
QQQ   223.47 (+0.04%)
AAPL   316.91 (-0.57%)
FB   221.13 (-0.45%)
MSFT   166.98 (-0.07%)
GOOGL   1,483.87 (+0.29%)
AMZN   1,882.57 (+0.96%)
CGC   24.10 (-3.17%)
NVDA   248.28 (-0.40%)
BABA   222.18 (-2.31%)
MU   58.91 (+2.17%)
GE   11.68 (-1.10%)
TSLA   543.81 (+6.52%)
AMD   51.15 (+0.43%)
T   38.63 (+0.63%)
ACB   2.00 (-6.12%)
F   9.19 (+0.33%)
NFLX   337.57 (-0.62%)
PRI   127.04 (-1.08%)
BAC   34.38 (-0.95%)
GILD   62.67 (-0.49%)
S&P 500   3,324.26 (-0.16%)
DOW   29,223.57 (-0.42%)
QQQ   223.47 (+0.04%)
AAPL   316.91 (-0.57%)
FB   221.13 (-0.45%)
MSFT   166.98 (-0.07%)
GOOGL   1,483.87 (+0.29%)
AMZN   1,882.57 (+0.96%)
CGC   24.10 (-3.17%)
NVDA   248.28 (-0.40%)
BABA   222.18 (-2.31%)
MU   58.91 (+2.17%)
GE   11.68 (-1.10%)
TSLA   543.81 (+6.52%)
AMD   51.15 (+0.43%)
T   38.63 (+0.63%)
ACB   2.00 (-6.12%)
F   9.19 (+0.33%)
NFLX   337.57 (-0.62%)
PRI   127.04 (-1.08%)
BAC   34.38 (-0.95%)
GILD   62.67 (-0.49%)
S&P 500   3,324.26 (-0.16%)
DOW   29,223.57 (-0.42%)
QQQ   223.47 (+0.04%)
AAPL   316.91 (-0.57%)
FB   221.13 (-0.45%)
MSFT   166.98 (-0.07%)
GOOGL   1,483.87 (+0.29%)
AMZN   1,882.57 (+0.96%)
CGC   24.10 (-3.17%)
NVDA   248.28 (-0.40%)
BABA   222.18 (-2.31%)
MU   58.91 (+2.17%)
GE   11.68 (-1.10%)
TSLA   543.81 (+6.52%)
AMD   51.15 (+0.43%)
T   38.63 (+0.63%)
ACB   2.00 (-6.12%)
F   9.19 (+0.33%)
NFLX   337.57 (-0.62%)
PRI   127.04 (-1.08%)
BAC   34.38 (-0.95%)
GILD   62.67 (-0.49%)
Log in
(Ad)
One undiscovered bank expects to pay out $332 million in 2019! And now's your chance to claim a 10.6% dividend - with MONTHLY PAYMENTS. This FREE special report reveals important details - including NAME, TICKER SYMBOL, and urgent payment information.

Viveve Medical Price Target & Analyst Ratings (NASDAQ:VIVE)

$1.18
+0.09 (+8.26 %)
(As of 01/21/2020 03:25 PM ET)
Today's Range
$1.09
Now: $1.18
$1.58
50-Day Range
$0.81
MA: $0.92
$1.26
52-Week Range
$0.79
Now: $1.18
$125.00
Volume843,455 shs
Average Volume1.38 million shs
Market Capitalization$1.75 million
P/E RatioN/A
Dividend YieldN/A
Beta0.11

Analyst Ratings

Viveve Medical (NASDAQ:VIVE) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
5 Wall Street analysts have issued ratings and price targets for Viveve Medical in the last 12 months. Their average twelve-month price target is $2.40, suggesting that the stock has a possible upside of 103.39%. The high price target for VIVE is $6.00 and the low price target for VIVE is $0.20. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.001.831.83
Ratings Breakdown: 1 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.40$2.05$2.24$2.24
Price Target Upside: 103.39% upside120.43% upside1,422.77% upside1,301.75% upside

Viveve Medical (NASDAQ:VIVE) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

(Ad)


Investors looking for the best way to potentially double their money in 2020 -- regardless of whether the overall markets are up or down -- should look no further than these 3 unique stocks.

This Special Report reveals the names of these stocks and provides everything you need to invest right away.

Viveve Medical (NASDAQ:VIVE) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
12/3/2019LADENBURG THALM/SH SHUpgradeNeutral ➝ BuyHigh
8/9/2019Maxim GroupReiterated RatingHoldMedium
7/23/2019MizuhoDowngradeBuy ➝ Underperform$4.00 ➝ $0.20N/A
7/23/2019Raymond JamesDowngradeOutperform ➝ Market PerformN/A
7/22/2019Stifel NicolausDowngradeBuy ➝ Hold$3.00 ➝ $1.00N/A
1/18/2019Craig HallumSet Price TargetHold$1.00High
(Data available from 1/21/2018 forward)
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel